Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix.

[1]  M. Matin,et al.  Cancer stem cells in human digestive tract malignancies , 2015, Tumor Biology.

[2]  E. Levine,et al.  Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases , 2014, Annals of Surgical Oncology.

[3]  Pamela R. Portschy,et al.  The Rise in Appendiceal Cancer Incidence: 2000–2009 , 2015, Journal of Gastrointestinal Surgery.

[4]  R. Donehower,et al.  Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study. , 2014, The Lancet. Oncology.

[5]  K. Nishio,et al.  Targeting MET Amplification as a New Oncogenic Driver , 2014, Cancers.

[6]  A. Saftoiu,et al.  Stem Cells, Colorectal Cancer and Cancer Stem Cell Markers Correlations , 2014, Current health sciences journal.

[7]  E. Levine,et al.  Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. , 2014, Journal of the American College of Surgeons.

[8]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[9]  R. Govindan,et al.  Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Joshua F. McMichael,et al.  DGIdb - Mining the druggable genome , 2013, Nature Methods.

[11]  W. Birchmeier,et al.  Targeting MET in cancer: rationale and progress , 2012, Nature Reviews Cancer.

[12]  T. Chua,et al.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  D. Hsu,et al.  Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. , 2012, Journal of the American College of Surgeons.

[14]  B. Moran,et al.  Operative Findings, Early Complications, and Long-Term Survival in 456 Patients With Pseudomyxoma Peritonei Syndrome of Appendiceal Origin , 2011, Diseases of the colon and rectum.

[15]  D. Elias,et al.  Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  R. Wolff,et al.  Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin , 2010, Cancer.

[17]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[18]  E. Levine,et al.  Adenocarcinoma of the Appendix Is Rarely Detected by Colonoscopy , 2009, Journal of Gastrointestinal Surgery.

[19]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[20]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[21]  S. Andreola,et al.  Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) , 2008, Annals of Surgical Oncology.

[22]  E. Levine.  Appendiceal Carcinoma with Peritoneal Dissemination: Outcomes for the Best of the Best , 2007, Annals of Surgical Oncology.

[23]  P. Sugarbaker,et al.  Critical Analysis of Treatment Failure After Complete Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Dissemination From Appendiceal Mucinous Neoplasms , 2007, Annals of Surgical Oncology.

[24]  K. Geisinger,et al.  Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature Review , 2006, The American journal of surgical pathology.

[25]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[27]  L. Sobin,et al.  Primary malignant neoplasms of the appendix , 2002, Cancer.

[28]  L. Sobin,et al.  PRIMARY MALIGNANT NEOPLASMS OF THE APPENDIX: A POPULATIONBASED STUDY FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END-RESULTS PROGRAM , 2002 .

[29]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[30]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[32]  R. Kurman,et al.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". , 1995, The American journal of surgical pathology.

[33]  D. Collins.  71,000 HUMAN APPENDIX SPECIMENS. A FINAL REPORT, SUMMARIZING FORTY YEARS' STUDY. , 1963, American journal of proctology.

[34]  Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .